Sign up to see all 5.
Sign up to see all 5.
A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
GG
GordonMD Global Investments LP
|
4.2M | 6.86% | Unchanged | Q4 '25 | 18.3% | |
|
Shares held by quarter
Peak holding4.4M (Q4'25)
Change over 8 quarters+4.2M
Share of the company6.860%
|
||||||
|
GS
Gilead Sciences, Inc.
|
4.1M | 6.67% | Unchanged | 2024 | 2.2% | |
|
Shares held by quarter
Peak holding4.1M (Q4'24)
Change over 8 quarters+4.1M
Share of the company6.670%
|
||||||
28 more super investors behind a free account
See every manager holding Kyverna Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$12.5M | 1.4M | 2.27% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$9.57M | 1.1M | 1.74% | 0.01% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Kyverna Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CF
Cohen Fred E
Insider
|
4.5M | 7.35% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company7.350%
|
||||||
|
SB
Seidenberg Beth C
Insider
|
891.0K | 1.44% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company1.440%
|
||||||
11 more holders behind a free account
See every insider and 5%+ holder of Kyverna Therapeutics, Inc..
Sign up freeLoading...